Colgate-Palmolive India FY26: Q4 growth rebounds as premiumisation and consumption drive the playbook

Colgate-Palmolive (India) closed FY26 on a stronger note than it began. The March quarter delivered a clear acceleration, with net sales of ₹1,583 crore, up 9.0% year on year. Domestic net sales growth was 9.2%. Profitability stayed robust, backed by a high gross margin of 69.6% and an EBITDA margin of 32.2%. Net profit after tax for Q4 was ₹353 crore.

The full year, however, reflected the uneven demand environment the company navigated through earlier quarters. FY26 net sales were ₹5,984 crore, flat year on year. NPAT for the year was ₹1,325 crore, down 1.8% year on year excluding one-offs, exceptional items, and the GST-led inverted duty structure impact referenced by management.

The management narrative across the presentation and concall was consistent: accelerate premiumisation, keep investing behind the brand, and expand category consumption, while protecting the company’s best-in-class margin profile through cost-savings programs.

Q4 performance: growth returns with resilient margins

Q4 FY26 was framed as a broad-based recovery. Management said growth was seen across core and premium portfolios, spanning toothpaste, toothbrushes, and personal care. Brand investments also stepped up. Advertising and brand investments in the quarter were ₹199 crore, equal to 12.6% of net sales.

Gross margin remained high at 69.6%, while EBITDA margin improved sequentially to 32.2%. The CFO noted an inverted duty structure impact from the GST rate change, which he quantified as about 160 basis points in Q4.

For FY26, gross margin was 69.3% and EBITDA margin was 31.2%. The company positioned this as resilient and superior to peers, while acknowledging headwinds from commodities, currency, and the ongoing GST structure impact.

Category consumption: pushing habit creation and access

Colgate continues to anchor its strategy on expanding category consumption. Management repeatedly described the company’s responsibility to lead toothpaste category growth in India.

A key pillar remains Colgate Bright Smiles, Bright Futures, which the company said engages over 10 million children each year, across 10 plus states and more than 35,000 schools. Management also highlighted eight state government partnerships and efforts to make oral health a national policy priority.

One of the most discussed initiatives was the dentist check-up access program via QR codes on product packs. Management stated this QR-based program is now on more than 500 million packs and has already seen close to one million people avail a check-up in six to eight weeks. In response to an analyst question, the CEO shared results from an earlier version of the program: 4.5 million people scanned, and management estimates about 20% of those consumers visited a dentist.

The company also described a rural pilot in Uttar Pradesh aimed at addressing the stated issue that more than 50% of rural Indians do not brush daily. The pilot included wall paintings, street plays, and school-led interventions. The company cited results from a 2025 study: attitude up 7%, brush once up 7%, and brush twice up 17% on claimed behaviour.

This consumption focus is not positioned as separate from premiumisation. Management said the QR program delivers high-quality oral health and lifestyle data, which can then be used for product development and audience targeting.

Premiumisation: bigger bets on Total, Visible White, and therapeutics

The second strategic pillar is described as transformatively accelerating oral care premiumisation. Management argued that this pillar has seen a step change.

Colgate Total was positioned as a technology-led prevention platform, supported by Rahul Dravid and scale activation via IPL. Colgate Visible White and Visible White Purple were framed as tapping into a whitening segment where management claimed 42% of Indian consumers have interest in whiter teeth, and where the segment is growing faster than the overall category.

During Q&A, management addressed competitor launches of similar whitening products and said the segment is expanding while Colgate continues to hold the lion’s share of the segment. Management also stated that premium toothpaste share of business has increased by about 35% over the last two years, although they did not disclose the current share.

The third element of premiumisation is therapeutics. The company highlighted gum problems as a large unmet need and positioned PerioGard as a gum care system across toothpaste, toothbrush, and mouthwash. Management said PerioGard net sales are doubling annually. They also noted that PerioGard became the first toothpaste brand to be endorsed by the Indian Society of Periodontology in May 2026.

Management also provided detail on the professional channel. The CEO said the B2B channel to dentists has grown at about 50% to 60% CAGR over two years, supported by a field force of a little over 150 people, with plans to augment this force.

Margin engine and capital allocation: protect gross margin, reinvest for growth

Colgate’s financial messaging is built around a simple model: protect gross margins, fund the growth, and return cash to shareholders.

The company highlighted a Funding the Growth savings program across procurement, manufacturing efficiencies, automation, and localization. It also described revenue growth management levers: strategic pricing, accelerating premiumisation, upsizing value packs, and efficient promotional spends.

On pricing, the CFO explained that Q4 pricing was largely anniversary pricing and that the company has not taken major pricing post-GST. However, he stated that some pricing has been put through and should reach the market over the next few weeks, in low single digits, with variation by category.

On margins, management was careful not to offer a fixed EBITDA target. The CFO said gross margins should remain in range over the next two quarters, but EBITDA will be calibrated based on advertising levels, since management is seeing good response to stepped-up advertising.

The company also addressed the GST inverted duty structure issue. The CFO stated it will be ongoing and discussed mitigation steps: operational efficiencies, representations to government for refunds in non-manufacturing states, and supplier representations for lower input GST rates.

Shareholder returns remain consistent. The company declared a second interim dividend of ₹24 per share, taking the total FY26 dividend to ₹48 per share. Management also stated it follows a strategy of paying out virtually 100% of NPAT as dividend. The company reported cash generation of ₹1,806 crore and ROCE of 121% for FY25-26.

Key investor takeaways

Colgate-Palmolive India’s FY26 shows a familiar pattern for strong consumer franchises: steady gross margins, meaningful brand spending, and a strong cash return framework, even when topline growth is uneven.

The positive signal for investors is the Q4 rebound and management’s confidence that it is not only a base effect, but also driven by stronger core product performance and rapid premium portfolio growth. The key monitorables remain competitive promotional intensity, commodity and currency volatility, and the persistence of the GST inverted duty structure drag.

For FY27, management did not provide numeric growth targets, but did state a preference for balanced growth between volume and pricing, continued premiumisation, and a willingness to step up investments where elasticity remains strong.